RAMM Pharma Corp. (CSE:RAMM)

Market Cap	1.19M
Revenue (ttm)	4.10M
Net Income (ttm)	-13.71M
Shares Out	119.39M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	69,000
Average Volume	10,871
Open	0.0150
Previous Close	0.0100
Day's Range	0.0150 - 0.0150
52-Week Range	0.0100 - 0.0250
Beta	0.22
RSI	40.10
Earnings Date	Sep 26, 2025

About RAMM Pharma

RAMM Pharma Corp. engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland. It offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products, as well as resells medical supplies products; and sells medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: RAMM

Financial Performance

In 2024, RAMM Pharma's revenue was 4.34 million, a decrease of -14.28% compared to the previous year's 5.07 million. Losses were -16.50 million, 113.7% more than in 2023.